HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Delivery of chemotherapeutic agents using drug-loaded irradiated tumor cells to treat murine ovarian tumors.

AbstractBACKGROUND:
Ovarian cancer is the leading cause of death among women with gynecologic malignancies in the United States. Advanced ovarian cancers are difficult to cure with the current available chemotherapy, which has many associated systemic side effects. Doxorubicin is one such chemotherapeutic agent that can cause cardiotoxicity. Novel methods of delivering chemotherapy without significant side effects are therefore of critical need.
METHODS:
In the current study, we generated an irradiated tumor cell-based drug delivery system which uses irradiated tumor cells loaded with the chemotherapeutic drug, doxorubicin.
RESULTS:
We showed that incubation of murine ovarian cancer cells (MOSEC) with doxorubicin led to the intracellular uptake of the drug (MOSEC-dox cells) and the eventual death of the tumor cell. We then showed that doxorubicin loaded MOSEC-dox cells were able to deliver doxorubicin to MOSEC cells in vivo. Further characterization of the doxorubicin transfer revealed the involvement of cell contact. The irradiated form of the MOSEC-dox cells were capable of treating luciferase-expressing MOSEC tumor cells (MOSEC/luc) in C57BL/6 mice as well as in athymic nude mice resulting in improved survival compared to the non drug-loaded irradiated MOSEC cells. Furthermore, we showed that irradiated MOSEC-dox cells was more effective compared to an equivalent dose of doxorubicin in treating MOSEC/luc tumor-bearing mice.
CONCLUSIONS:
Thus, the employment of drug-loaded irradiated tumor cells represents a potentially innovative approach for the delivery of chemotherapeutic drugs for the control of ovarian tumors.
AuthorsDaejin Kim, Talia Hoory, Archana Monie, Annie Wu, Wei-Ting Hsueh, Sara I Pai, Chien-Fu Hung
JournalJournal of biomedical science (J Biomed Sci) Vol. 17 Pg. 61 (Jul 26 2010) ISSN: 1423-0127 [Electronic] England
PMID20659328 (Publication Type: Comparative Study, Evaluation Study, Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Drug Carriers
  • Doxorubicin
  • Luciferases
Topics
  • Animals
  • Doxorubicin (metabolism, pharmacokinetics, therapeutic use)
  • Drug Carriers (therapeutic use)
  • Drug Therapy (methods)
  • Female
  • Flow Cytometry
  • Luciferases
  • Mice
  • Mice, Inbred C57BL
  • Ovarian Neoplasms (drug therapy)
  • Tumor Cells, Cultured (metabolism, radiation effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: